Showing results (101-110 of 204) with videos related to
Sort By:
Pageof 21
Molecular Biomedicine|December 26, 2024
Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studiesManzar Alam, Mehak Gulzar, Mohammad Salman Akhtar, et al.International Journal of Biological Macromolecules|June 15, 2020
Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseasesSaleha Anwar, Anas Shamsi, Rajiv K Kar, et al.International Journal of Molecular Sciences|June 10, 2022
Unraveling the Binding Mechanism of Alzheimer's Drugs with Irisin: Spectroscopic, Calorimetric, and Computational ApproachesRashid Waseem, Anas Shamsi, Tanzeel Khan, et al.International Journal of Biological Macromolecules|June 19, 2023
Inhibitory potential of N-acetylaspartate against protein glycation, AGEs formation and aggregation: Implication of brain osmolyte in glycation-related complicationsRashid Waseem, Tanzeel Khan, Anas Shamsi, et al.Frontiers in Pharmacology|April 3, 2025
Unraveling human transferrin-tryptamine interactions: a computational and biophysical approach to Alzheimer's disease therapeuticsMohammed Alrouji, Mohammed S Alshammari, Taghreed A Majrashi, et al.Scientific Reports|November 19, 2025
Exploring the binding of cinchonine with human transferrin: combined experimental and computational approachesAnas Shamsi, Nur Nadhirah Mohamad Zain, Khuzin Dinislam, et al.Plos One|January 3, 2025
Virtual screening and molecular dynamics simulations identify repurposed drugs as potent inhibitors of Histone deacetylase 1: Implication in cancer therapeuticsMohammed Alrouji, Sabina Yasmin, Mohammed S Alshammari, et al.Plos One|December 19, 2024
Unveiling Cathepsin B inhibition with repurposed drugs for anticancer and anti-Alzheimer's drug discoveryMohammed Alrouji, Sabina Yasmin, Mohammed S Alshammari, et al.Journal of Cellular Biochemistry|June 14, 2021
Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseasesSaleha Anwar, Shama Khan, Anas Shamsi, et al.Journal of Biomolecular Structure & Dynamics|May 5, 2025
Identification of high-affinity inhibitors for epoxide hydrolase 2 from repurposed drugs in Parkinson's disease therapeuticsAnas Shamsi, Moyad Shahwan, Sohaib Naseem Khan, et al.Pageof 21